Is Gammagard the One the Alzheimer's Community Has Been Waiting For?
This is re-posted from the Alzheimer's Reading Room. You might want to take a look at Baxter. However, there is still a lot of risk going into the results of the Phase 3 clinical trial
This is the first study to report long term stabilization of Alzheimer's symptoms over a period of 36 months .
Alzheimer's Reading Room
Eleven patients who were treated over a 36 month period with IVIG/Gammagard had favorable outcomes in terms of their thinking abilities, behavior and daily function.
To be clear, the already existing symptoms of the Alzheimer's patients being studied did not improve; however, patients did not show any further decline on measures of cognition, memory, daily functioning or mood over the three years.
